“Serum Institute of India said on Thursday it would manufacture an experimental tuberculosis vaccine under an ​agreement with the Gates Medical Research Institute, in what is ‌likely to be the first new TB shot in more than 100 years if approved.

The novel vaccine candidate, M72/AS01E, has been in development for two decades and ​is currently in a late-stage clinical trial.

Serum Institute plans to invest ​more than $100 million to scale up manufacturing capacity and prepare ⁠for future vaccine supply, pending approval, the company said.

Under the agreement, ​Gates MRI, founded by the Gates Foundation, will transfer the technology and ​know-how needed to manufacture the vaccine antigen and enable large-scale production, Serum Institute said.”

From Reuters.